Mitophagy in depression: Pathophysiology and treatment targets

Area of Science:

• Cellular Biology
• Neuroscience
• Pathophysiology

Background:

• Mitochondria are crucial for cellular homeostasis.
• Defective mitochondria increase inflammation via ROS and mtDNA release.
• Mitophagy selectively removes damaged mitochondria; its impairment leads to accumulation.

Purpose of the Study:

• To review the role of impaired mitophagy in depression pathophysiology.
• To discuss potential therapeutic strategies targeting mitophagy for depression.

Main Methods:

• Literature review and synthesis of existing research.
• Analysis of the link between mitochondrial dysfunction, inflammation, and depression.
• Exploration of mitophagy modulation as a therapeutic approach.

Main Results:

• Impaired mitophagy contributes to the accumulation of dysfunctional mitochondria.
• This accumulation exacerbates inflammation, a known factor in depression.
• Evidence links mitochondrial dysfunction and inflammation to depression pathogenesis.

Conclusions:

• Impaired mitophagy is a significant factor in depression.
• Targeting mitophagy pathways presents a promising therapeutic avenue for depression treatment.